Hva betyr "Tøm"?
Dyret bærer ikke mutasjonen. Det vil ikke utvikle sykdommen og vil ikke gi det videre.
Cerebellar Abiotrophy (CA) is a genetic disorder affecting horses, leading to progressive loss of coordination and balance. A DNA test for CA helps identify carriers and affected horses, enabling breeders to make informed decisions and reduce the risk of passing this debilitating condition to offspring. Early detection through genetic testing is crucial for managing breeding programs and maintaining healthy equine populations. This test is especially important for breeds prone to CA, such as Arabian horses. By using the CA DNA test, owners can ensure better care and improve the overall welfare of their horses. Stay proactive and protect your equine investment with reliable genetic screening for Cerebellar Abiotrophy.
Cerebellar Abiotrophy (CA) is a genetic disorder in horses that affects the cerebellum, leading to coordination and balance issues. A DNA test can identify carriers and affected horses by detecting the specific mutation responsible for CA. This test helps breeders make informed decisions to avoid producing affected foals. Early diagnosis through DNA testing improves management and care for affected horses. Overall, the CA DNA test is a valuable tool for promoting healthier breeding practices.
Denne DNA-testen er inkludert fra pakken vår Basic — og er også en del av pakkene Basic, Standard, Advanced, Complete.
Se DNA-testpakker →Cerebellar Abiotrophy (CA) is a neurological condition observed in horses, characterized by the degeneration of the cerebellum, a part of the brain responsible for coordination and balance. This condition typically manifests in young horses, often between the ages of 6 months and 3 years, leading to significant motor dysfunction. Affected horses may exhibit symptoms such as incoordination, difficulty standing, and abnormal gait, which can severely impact their quality of life and training potential.
CA is recognized as a hereditary disorder, often associated with specific genetic mutations. The condition arises due to the improper development and subsequent degeneration of Purkinje cells within the cerebellum. These cells play a crucial role in motor control, and their loss leads to the clinical signs observed in affected individuals. Understanding the genetic underpinnings of CA has paved the way for DNA testing, which can identify carriers and help breeders make informed decisions.
The clinical signs of CA can vary in severity but generally include a range of neurological deficits. Common symptoms include a lack of coordination, especially in the hind limbs, a wide-based stance, and difficulty with balance. Affected horses may also show signs of intention tremors, where they exhibit tremors when trying to perform tasks such as eating or drinking. These symptoms can significantly hinder the horse's ability to engage in routine activities and can lead to frustration for both the animal and its handler.
Diagnosing CA typically involves a combination of clinical evaluation and genetic testing. Veterinarians assess the horse's neurological function and may perform additional tests to rule out other conditions that could cause similar symptoms. Genetic testing plays a crucial role in confirming the diagnosis and understanding the horse's genetic predisposition to the condition.
Currently, there is no cure for Cerebellar Abiotrophy, and management focuses on supportive care and ensuring the horse's safety. Affected horses may require specialized handling and training approaches to accommodate their coordination issues. The prognosis for horses with CA varies; some may lead relatively normal lives with adaptations, while others may need to be retired from work due to the severity of their symptoms.
Cerebellar Abiotrophy is a significant concern in equine health, particularly due to its genetic nature and impact on horse performance and welfare. DNA testing serves as a valuable tool for breeders and owners, providing insights into the likelihood of developing this condition. Increased awareness and understanding of CA are essential for effective management and the continued health of affected horses.
Dyret bærer ikke mutasjonen. Det vil ikke utvikle sykdommen og vil ikke gi det videre.
Nei. Dyret er generelt sunt, men kan overføre mutasjonen til dens avkom.
Den har to muterte kopier. Kliniske tegn forventes avhengig av sykdommen. Det skal ikke avles.
Noen sykdommer er kjønnsbundne, så uttrykket deres varierer avhengig av dyrs kjønn.
This DNA test detects the mutation associated with Cerebellar Abiotrophy (CA) in order to identify clear, carrier, or at-risk animals.
DNA-testing hjelper oppdrettere med å planlegge sikrere parringer og redusere risikoen for å overføre mutasjonen til avkom.
Arvemodusen som er rapportert for denne testen er autosomal recessiv.
This test analyses the mutation MUTYH c.541-13539C/T.
Ikke nødvendigvis. Tolkning avhenger av arvemønsteret og den resulterende genotypen.
Brault Leah S, Cooper Caitlin A, Famula Thomas R, Murray James D, Penedo M Cecilia T. Mapping of equine cerebellar abiotrophy to ECA2 and identification of a potential causative mutation affecting expression of MUTYH. Genomics. 2011 Feb;97(2):121-9. doi: 10.1016/j.ygeno.2010.11.006. Epub 2010 Nov 30.
Ditt privatliv, ditt valg
Vi bruker viktige informasjonskapsler for å drive nettstedet. Valgfrie informasjonskapsler (som leverandører av innebygd innhold) er deaktivert som standard og er bare aktivert hvis du samtykker. Du kan endre valget ditt når som helst ved å bruke "Cookies"-knappen.
Nødvendig for kjernefunksjoner og sikkerhet. Alltid aktivert.
Forbedrer funksjoner som lagring av preferanser eller ikke-annonsering.
Hjelper oss å forstå nettstedets bruk. Deaktivert som standard.
Annonsering/sporing på tvers av nettsteder (noen video-/kartinnbygginger). Deaktivert som standard.